May 02, 2017 - The big biotech's revenue and earnings fell yet again in Q1. But there were a few bright spots.
Apr 27, 2017 - AbbVie Inc. (ABBV) reported better-than-expected results in the first-quarter of 2017. The company surpassed both earnings and sales expectations.
Apr 27, 2017 - AbbVie, Inc. (NYSE:ABBV)Q1 2017 Earnings CallApril 27, 2017 9:00 am ETExecutivesElizabeth Shea - AbbVie, Inc.Richard A. Gonzalez - AbbVie, Inc.Michael E. Severino - AbbVie, Inc.William J. Chase - AbbV
Apr 27, 2017 - AbbVie rides its blockbuster anti-inflammatory drug, Humira, to another strong quarter, but the question remains: How long can this juggernaut can last?
Apr 27, 2017 - AbbVie's first-quarter earnings came in at $1.28 per share, beating the Zacks Consensus Estimate of $1.26.
Apr 26, 2017 - Tracey brings you the companies with the best earnings charts each week.
Apr 26, 2017 - Celgene, AbbVie and Bristol-Myers Squibb are expected to report earnings on Apr 27.
Apr 25, 2017 - Gilead Sciences Inc. (GILD) is scheduled to report first-quarter 2017 results on May 2, after the market closes.
Apr 25, 2017 - Biogen Inc. (BIIB) reported better-than-expected results in the first-quarter of 2017. The company surpassed expectations both for earnings and sales.
Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.